This Article Full Text Full Text (PDF) Supplemental material Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Morikawa, S. Articles by Kojima, A. Search for Related Content PubMed PubMed Citation Articles by Morikawa, S. Articles by Kojima, A. Pubmed/NCBI databases Protein Substance via MeSH Medline Plus Health Information Smallpox

 Previous Article  |  Next Article 

Journal of Virology, September 2005, p. 11873-11891, Vol. 79, No. 18
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.18.11873-11891.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

An Attenuated LC16m8 Smallpox Vaccine: Analysis of Full-Genome Sequence and Induction of Immune Protection

Shigeru Morikawa,^1, Tokuki Sakiyama,^2,3, Hideki Hasegawa,^4, Masayuki Saijo,¹ Akihiko Maeda,^1, Ichiro Kurane,¹ Go Maeno,³ Junko Kimura,³ Chie Hirama,³ Teruhiko Yoshida,^2,3 Yasuko Asahi-Ozaki,⁴ Tetsutaro Sata,⁴ Takeshi Kurata,⁴ and Asato Kojima^4*

Department of Virology 1,¹ Department of Pathology, National Institute of Infectious Diseases,⁴ Genetics Division,² Center for Medical Genomics, National Cancer Center Research Institute, Tokyo, Japan³

Received 1 December 2004/ Accepted 7 June 2005

The potential threat of smallpox bioterrorism has made urgent the development of lower-virulence vaccinia virus vaccines. An attenuated LC16m8 (m8) vaccine was developed in 1975 from the Lister strain used in the World Health Organization smallpox eradication program but was not used against endemic smallpox. Today, no vaccines can be tested with variola virus for efficacy in humans, and the mechanisms of immune protection against the major intracellular mature virion (IMV) and minor extracellular enveloped virion (EEV) populations of poxviruses are poorly understood. Here, we determined the full-genome sequences of the m8, parental LC16mO (mO), and grandparental Lister (LO) strains and analyzed their evolutionary relationships. Sequence data and PCR analysis indicated that m8 was a progeny of LO and that m8 preserved almost all of the open reading frames of vaccinia virus except for the disrupted EEV envelope gene B5R. In accordance with this genomic background, m8 induced 100% protection against a highly pathogenic vaccinia WR virus in mice by a single vaccination, despite the lack of anti-B5R and anti-EEV antibodies. The immunogenicity and priming efficacy with the m8 vaccine consisting mainly of IMV were as high as those with the intact-EEV parental mO and grandparental LO vaccines. Thus, mice vaccinated with 10⁷ PFU of m8 produced low levels of anti-B5R antibodies after WR challenge, probably because of quick clearance of B5R-expressing WR EEV by strong immunity induced by the vaccination. These results suggest that priming with m8 IMV provides efficient protection despite undetectable levels of immunity against EEV.

---

* Corresponding author. Mailing address: Department of Pathology, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640, Japan. Phone: 81-3-5285-1189. Fax: 81-3-5285-1189. E-mail: akojima{at}nih.go.jp.

Supplemental material for this article may be found at http://jvi.asm.org.

S.M., T.S., and H.H. contributed equally to this work.

Present address: Graduate School of Veterinary Medicine, Hokkaido University, Kita 18, Nishi 9, Kita-ku, Sapporo 060-0818, Japan.

---

Journal of Virology, September 2005, p. 11873-11891, Vol. 79, No. 18
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.18.11873-11891.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Meseda, C. A., Mayer, A. E., Kumar, A., Garcia, A. D., Campbell, J., Listrani, P., Manischewitz, J., King, L. R., Golding, H., Merchlinsky, M., Weir, J. P. (2009). Comparative Evaluation of the Immune Responses and Protection Engendered by LC16m8 and Dryvax Smallpox Vaccines in a Mouse Model. CVI 16: 1261-1271 [Abstract] [Full Text]  
• Saito, T., Fujii, T., Kanatani, Y., Saijo, M., Morikawa, S., Yokote, H., Takeuchi, T., Kuwabara, N. (2009). Clinical and Immunological Response to Attenuated Tissue-Cultured Smallpox Vaccine LC16m8. JAMA 301: 1025-1033 [Abstract] [Full Text]  
• Meisinger-Henschel, C., Schmidt, M., Lukassen, S., Linke, B., Krause, L., Konietzny, S., Goesmann, A., Howley, P., Chaplin, P., Suter, M., Hausmann, J. (2007). Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara. J. Gen. Virol. 88: 3249-3259 [Abstract] [Full Text]  
• Garcel, A., Crance, J.-M., Drillien, R., Garin, D., Favier, A.-L. (2007). Genomic sequence of a clonal isolate of the vaccinia virus Lister strain employed for smallpox vaccination in France and its comparison to other orthopoxviruses. J. Gen. Virol. 88: 1906-1916 [Abstract] [Full Text]  
• Tang, J., Murtadha, M., Schnell, M., Eisenlohr, L. C., Hooper, J., Flomenberg, P. (2006). Human T-cell responses to vaccinia virus envelope proteins.. J. Virol. 80: 10010-10020 [Abstract] [Full Text]  
• Tulman, E. R., Delhon, G., Afonso, C. L., Lu, Z., Zsak, L., Sandybaev, N. T., Kerembekova, U. Z., Zaitsev, V. L., Kutish, G. F., Rock, D. L. (2006). Genome of horsepox virus.. J. Virol. 80: 9244-9258 [Abstract] [Full Text]  
• Saijo, M., Ami, Y., Suzaki, Y., Nagata, N., Iwata, N., Hasegawa, H., Ogata, M., Fukushi, S., Mizutani, T., Sata, T., Kurata, T., Kurane, I., Morikawa, S. (2006). LC16m8, a Highly Attenuated Vaccinia Virus Vaccine Lacking Expression of the Membrane Protein B5R, Protects Monkeys from Monkeypox.. J. Virol. 80: 5179-5188 [Abstract] [Full Text]